PLA2G4B anticorps (AA 514-781)
-
- Antigène Voir toutes PLA2G4B Anticorps
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Épitope
- AA 514-781
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PLA2G4B est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Cytosolic phospholipase A2 beta protein (514-781AA)
- Isotype
- IgG
-
-
- Indications d'application
- Recommended dilution: WB:1:1000-1:5000, IHC:1:200-1:500, IF:1:50-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
- Autre désignation
- PLA2G4B (PLA2G4B Produits)
- Synonymes
- anticorps HsT16992, anticorps cPLA2-beta, anticorps A030011C02Rik, anticorps Gm1013, anticorps phospholipase A2 group IVB, anticorps phospholipase A2, group IVB (cytosolic), anticorps PLA2G4B, anticorps Pla2g4b
- Sujet
-
Background: Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position with a preference for arachidonoyl phospholipids. Has a much weaker activity than PLA2G4A. Isoform 3 has calcium-dependent activity against palmitoyl-arachidonyl-phosphatidylethanolamine and low level lysophospholipase activity but no activity against phosphatidylcholine. Isoform 5 does have activity against phosphatidylcholine.
Aliases: PLA2G4B antibody, Cytosolic phospholipase A2 beta antibody, cPLA2-beta antibody, EC 3.1.1.4 antibody, Phospholipase A2 group IVB antibody
- UniProt
- P0C869
- Pathways
- ER-Nucleus Signaling, VEGF Signaling
-